Dr. reddy's laboratories announces the launch of venlafaxine er tablets in the u.s. market

Hyderabad, india & princeton, n.j.--(business wire)--dr. reddy's laboratories ltd. (bse: 500124, nse: drreddy, nyse: rdy, nseifsc: drreddy, along with its subsidiaries together referred to as “dr. reddy's”) today announced the launch of venlafaxine er tablets which is therapeutically equivalent to venlafaxine extended-release tablets, 150 mg and 225 mg, of osmotica pharmaceutical us llc approved by the u.s. food and drug administration (usfda). the brand and generic had u.s. sales of approximat
RDY Ratings Summary
RDY Quant Ranking